Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRHEA: Neoadjuvant Palbociclib + Endocrine Therapy in Early Breast Cancer
NCT03065621Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Jul 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Institut Jules Bordet. Started Jul 2017; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03065621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065621.